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Mycobacterium szulgai is a rare nontuberculous mycobacterium (NTM) pathogen reported 
in <1% of diseases related to mycobacterium. Its presence is clinically significant and 
is mostly found in immunocompromised individuals with an existing and/or underlying 
lung disease. Upon diagnosis and pathogen sensitivities, treatment is recommended 
with triple therapy over prolonged period of time to prevent complications and further 
respiratory deterioration. This type of pathogen mostly forms upper lobe cavitations and 
may radiologically and clinically resemble tuberculosis. 
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•  Grows at 37o in 12-25 days, Niacin (-), Nitrite (+)
•  Only AFB that has different light test based on 
temperature
  -  Scotochromogen at 37o
  -  Photochromogen at 25o
•  Unique characteristic of this species:
•  No human to human spread, environment is the 
source of human infections
In 2007, the American Thoracic Society (ATS) and the Infectious Diseases Society of America (IDSA) published 
diagnostic criteria for NTM infection. The guidelines consist of clinical, radiological, and microbiological criteria 
as listed = 1) pulmonary symptoms, nodular or cavitary opacities on chest radiograph, or a HRCT scan that 
show multifocal bronchiectasis with multiple small nodules, 2) appropriate exclusion of other diagnoses, such as 
tuberculosis, and 3) positive culture results from at least two separate expectorated sputum samples. 
Mycobacterium szulgai is a slow-growing NTM that presents as an opportunistic pathogen in individuals with 
systemic immune suppression or pulmonary disease. It accounts for less than 1% of all non-tuberculous 
mycobacterium infections. Pulmonary M. szulgai is often clinically identical to M. tuberculosis with symptoms such 
as weight loss, cough, hemoptysis and radiographic evidence of cavitary lesions. The demographic distribution is 
commonly in men above the age of 50 with risk factors such as tobacco or alcohol abuse with COPD and/or history 
of pulmonary tuberculosis. Diagnosis, as defined by American Thoracic Society – is with pulmonary symptoms, 
exclusion of other diseases with a positive culture, specifically from bronchial fluid. Given our patient’s demographic 
profile and ultimate diagnosis, it becomes important to keep this pathogen as part of a differential when there is 
suspicion for mycobacterial infection and even with detection of small numbers of M. szulgai, susceptibility testing 
and treatment should begin promptly given its long-term treatment and possible morbidity. 
A 59-year-old Caucasian male with oxygen dependent COPD presented with complaints 
of subjective fevers, chills, hemoptysis and fatigue after. He had a similar presentation 
one year ago when he was treated for right lobar necrotizing pneumonia with negative 
diagnostic work-up. Upon this admission, he was febrile at 101oF with CT chest showing 
left upper lobe cavitary pneumonia. Diagnostic work-up showed leukocytosis of 15,000 
with negative blood cultures. An acid-fast stain of bronchial washing fluid was positive 
and susceptibility testing demonstrated Mycobacterium szulgai. He was promptly started 
on triple therapy – Clarithromycin, Rifabutin and Bactrim DS for a 12 month period 
with routine blood work to monitor for side effects. Over the duration of treatment, his 
symptoms improved and his imaging showed interval improvements due to treatment. 
Case Report
American Thoracic Society Diagnostic Criteria of Nontuberculous) Mycobacterial Lung Disease 
Clinical criteria
1.  Pulmonary symptoms, nodular or cavitary opacities on chest radiograph, or an HRCT scan that 
shows multifocal bronchiectasis with multiple small nodules.
and
2.  Appropriate exclusion of other diagnoses.
Microbiological criteria
1.  Positive culture results from at least two separate expectorated sputum samples. (If the results 
from the initial sputum samples are nondiagnostic, consider repeat sputum AFB smears and 
cultures.)
or
2.  Positive culture results from at least one bronchial wash or lavage.
or
3.  Transbronchial or other lung bipsy with mycobacterial histopathologic features (granulomatous 
inflammation or AFB) and positive cultures for NTM or biposy showing mycobacterial 
histopathologic features (granulomatous inflammation or AFB) and one or more sputum or 
bronchial washings taht are culture positive for NTM.
Knowledge Survey
Figure 1: Right upper lobe lung cavitary lesion – a 
classic hallmark of NTM as presented in this case.
Introduction Discussion
25o C - Photochromogen
37o C - Scotochromogen
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